Together, these results demonstrate that a local anti-inflammatory treatment improved intestinal permeability and visceral hypersensitivity in a preclinical, spontaneous model of DGBI. Moreover, it supports a role for intestinal inflammation in the intestinal barrier defect and symptoms, further paving the way for additional evaluation of anti-inflammatory treatments, including budesonide, in DGBI.
Building similarity graph...
Analyzing shared references across papers
Loading...
Alison Accarie
Pauline Huyghe
Mathieu Méleine
Neurogastroenterology & Motility
KU Leuven
Building similarity graph...
Analyzing shared references across papers
Loading...
Accarie et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69a75bc7c6e9836116a23bdf — DOI: https://doi.org/10.1111/nmo.70233
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: